Filing Flows › Imax (IMAX) › R&D spending
Imax (IMAX) R&D spending by quarter
Imax's R&D spending was $1.9M in Q3 2026 (third quarter 2026), +15% from Q2 2026. Over the last 7 quarters it ranged from $1.3M (Q1 2025) to $1.9M (Q3 2026).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $1.9M | +15% | +26% |
| Q2 2026 | $1.7M | -8% | +7% |
| Q1 2026 | $1.8M | +24% | +37% |
| Q4 2025 | $1.5M | -4% | — |
| Q3 2025 | $1.5M | -2% | — |
| Q2 2025 | $1.5M | +17% | — |
| Q1 2025 | $1.3M | — | — |
Q3 2026 at a glance
Imax, Q3 2026: revenue $175M (+64% year over year), operating margin 42.9%, net earnings $114M, operating cash flow $86.1M. The chart follows the revenue to costs, profit and cash.
Questions
What is Imax's R&D spending?
Imax's R&D spending was $1.9M in Q3 2026 (third quarter 2026), +15% from Q2 2026.
How has Imax's R&D spending changed?
Over the last 7 quarters it ranged from $1.3M (Q1 2025) to $1.9M (Q3 2026).